Viewing Study NCT03662334

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2026-03-09 @ 5:50 AM
Study NCT ID: NCT03662334
Status: COMPLETED
Last Update Posted: 2019-02-01
First Post: 2018-08-13
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Continuous Subcutaneous Insulin Infusion (CSII) Pump Function in Subjects With Type 1 Diabetes With Recombinant Human Hyaluronidase (rHuPH20)
Sponsor: Halozyme Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 1 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetes View
None Type 1 Diabetes Mellitus View
None Type 1 Diabetes View
None T1DM View
None Continuous Subcutaneous Insulin Infusion (CSII) View
None CSII View
None Insulin pump View
None Insulin View
None rHuPH20 View
None Hylenex View
None recombinant human hyaluronidase (rHuPH20) View
None Recombinant hyaluronidase View